4M THERAPEUTICS INC.
4MTx is developing small molecules to treat neuropsychiatric disorders by enhancing neuroplasticity and reducing neuro-inflammation.
4M THERAPEUTICS INC.
Social Links:
Website Url:
http://www.4mtx.net
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Google Apps For Business Typekit LocalBusiness Schema
Current Employees Featured
Founder
Official Site Inspections
http://www.4mtx.net Semrush global rank: 8.64 M Semrush visits lastest month: 274
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "4M Therapeutics Inc."
4M Therapeutics
Driven by the desire to improve the lives of patients with central nervous system disorders, we use our living human brain cell platform to identify and develop better therapeutics.See details»
4M Therapeutics Inc. - Crunchbase Company Profile
4M Therapeutics Inc. (4MTx) develops therapies for central nervous system (CNS) disorders with blockbuster potential. We focus on targets implicated in โฆSee details»
4M Therapeutics Inc. - LinkedIn
4mtx.net 30 2 Comments Like Comment Share 4M Therapeutics Inc. 789 followers ... The SynGAP Resarch Fund is a great organization, and we appreciate the opportunity. Our work continues to advance.See details»
Platform - 4M Therapeutics
The challenge. Research on human brain cells was historically limited due to difficulty accessing and maintaining them in culture. Differences in physiology between humans and animals limit the ability of animal models to support drug development, making human brain cells an essential component of drug discovery.See details»
4M Therapeutics Inc. Information - RocketReach
4MTx is led by CEO Pablo Lapuerta, who has developed and launched multiple drugs. He introduced into clinical trials the first targeted CNS kinase inhibitor to show successful proof-of-concept data. Board Chair Don Hayden was previously President of Global Pharmaceuticals at Bristol Myers-Squibb and led the development and commercialization of CNS blockbuster โฆSee details»
4M Therapeutics Awarded $120,000 Grant from SynGAP Research โฆ
Skillman, NJ โ Nov. 12, 2024 โ 4M Therapeutics Inc. (4MTx), an early-stage biotechnology company developing treatments for neuropsychiatric and neurodegenerative diseases, today announced that the Company has been awarded a $120,000 grant from SynGAP Research Fund dba Cure SYNGAP1 (SRF) to evaluate central nervous system effects of novel glycogen โฆSee details»
4M Therapeutics Inc. Overview | SignalHire Company Profile
4MTx is a biotech developing best-in-class drugs that target key pathways in neural plasticity โ the ability of the brain to form new cells and connections. ... Organization Website: 4mtx.net : Social Links: Phone Number: 6178522795: 4M Therapeutics Inc. industries Biotech: Headquarters Location: Princeton, NJ, US Princeton, NJ, US : 4M ...See details»
4M Therapeutics Inc. | Montgomery Township, NJ, USA Startup
4MTx is a neuroscience biotech startup. Our technology platform from Harvard, MIT, and U. Washington uses live human brain cells in drug discovery. We focus on targets for a wide array of disorders like Alzheimer's disease and bipolar disorder for which our small molecule lead compound, 4MT2001, demonstrates efficacy like lithium in animals while promising much โฆSee details»
4M Therapeutics - VentureRadar
4m therapeutics inc. is a startup biotech company based on the principle that the study of human brain cells represents an important advance in neuroscience discovery. 4mtx has developed a pipeline of small molecules by studying their effects on brain cells derived from human induced pluripotent stem cells. the initial focus is bipolar disorder and alzheimer's disease, conditions โฆSee details»
4MT2001 - Drug Targets, Indications, Patents - Synapse
Originator Organization. 4M Therapeutics, Inc. Active Organization. 4M Therapeutics, Inc. Inactive Organization-Drug Highest ... mania, agitation in Alzheimerโs disease, neurodegeneration, and other CNS disorders. For more information, visit www.4mtx.net . 100 Deals associated with 4MT2001. Login to view more data. R&D Status. 10 top R&D ...See details»
4m Therapeutics Inc. · 5 Seminole Road, Skillman, NJ 08558-2325
4M THERAPEUTICS INC. is an entity in Skillman, New Jersey registered with the System for Award Management (SAM) of U.S. General Services Administration (GSA). The entity was registered on June 27, 2022 with Unique Entity ID (UEI) #WDPHLLVHZCR7, activated on July 18, 2023, expiring on July 16, 2024, and the business was started on January 13, 2021.See details»
4M Therapeutics Strengthens Executive Leadership Team with โฆ
Mar 4, 2024 Dr. Lee brings over 20 years of biotechnology industry and Wall Street experience. Skillman, NJ โ March 4, 2024 โ 4M Therapeutics Inc., an early-stage biotechnology company developing treatments for neuropsychiatric and neurodegenerative conditions, today announced the appointment of Kimberly Lee, D.O. as Chief Business Officer and member of the executive โฆSee details»
4M Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials
For more information, visit www.4mtx.net . 13 May 2024 ... The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, โฆSee details»
4M Therapeutics, Inc. (4M Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ โฆ
SKILLMAN, N.J.--( BUSINESS WIRE )--4M Therapeutics Inc. (4MTx), an early-stage biotechnology company developing treatments for neuropsychiatric and neurodegenerative diseases, today announced new preclinical data for its lead program, 4MT2001, a novel small molecule glycogen synthase kinase 3 beta (GSK3ฮฒ) inhibitor, that demonstrated clear central โฆSee details»
4M Therapeutics Inc. on LinkedIn: 4M Therapeutics Inc. Announces ...
4M Therapeutics Inc. Announces Oversubscribed $2.575 Million Financing Round โ 4M Therapeutics 4mtx.netSee details»
4M Therapeuticsโ Compounds to Be Utilized in Research Project โฆ
Oct 17, 2024 About 4M Therapeutics Inc. 4M Therapeutics Inc. (4MTx) is advancing treatments for neuropsychiatric and neurodegenerative diseases. The Company focuses on targets for a wide array of disorders and ...See details»
4M Therapeutics Presented Novel Preclinical Data at SOBP Annual โฆ
May 13, 2024 4M Therapeutics Inc. (4MTx) is advancing treatments for neuropsychiatric and neurodegenerative conditions. The Company focuses on targets for a wide array of disorders and indications. 4MTx applies unique insights from its living human brain cell platform, which was developed through a collaboration between Harvard, MIT, and the University of Washington to โฆSee details»
4M Therapeutics Inc. Email Format | 4mtx.net Emails
4mtx.net; gmail.com; View Similar People. Related Companies MapText, Inc. 6 $17m Orthobond LLC. 14 $12m RCN Telecom Services, Inc. 2 $6.6m Cardinal Partners (CP) 4 $1m Inside Edge Consulting Group. 33 $16.3m Princeton Montessori School. 41 ...See details»
4M Therapeutics Inc. Announces New Patent License Agreement
Jun 30, 2022 About 4MTx: 4M Therapeutics Inc. is a startup biotech company based on the principle that the study of human brain cells represents an important advance in neuroscience discovery. 4MTx has developed a pipeline of small molecules by studying their effects on brain cells derived from human induced pluripotent stem cells.See details»
4M Therapeutics Inc. Staff Directory & Email Format - ContactOut
Explore 4M Therapeutics Inc. staff directory for direct access to contact details on 4 employees including email format, email address and phone numbers.See details»